U.S. market Open. Closes in 5 hours

SDGR | Schrödinger, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 18.86 - 19.24
52 Week Range 16.67 - 38.00
Beta 1.82
Implied Volatility 56.64%
IV Rank 42.47%
Day's Volume 118,235
Average Volume 672,096
Shares Outstanding 72,796,533
Market Cap 1,388,593,867
Sector Healthcare
Industry Medical - Healthcare Information Services
IPO Date 2020-02-06
Valuation
Profitability
Growth
Health
P/E Ratio -7.69
Forward P/E Ratio 90.53
EPS -2.48
1YR Price Target 45.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 867
Country USA
Website SDGR
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
SDGR's peers: AMWL, DOCS, GDRX, VEEV, GEHC, TDOC, TXG, PGNY, CERT, HQY, RCM, ACCD, SHLT
*Chart delayed
Analyzing fundamentals for SDGR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see SDGR Fundamentals page.

Watching at SDGR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on SDGR Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙